OnKure Therapeutics, Inc. Class A Common Stock (OKUR)
PHARMACEUTICAL PREPARATIONS
OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is listed on Nasdaq, where it has traded since October 7, 2024.
- Listed On
- Nasdaq
- Listed Since
- October 7, 2024
- Employees
- 45
- Market Cap
- $117M
About OnKure Therapeutics, Inc. Class A Common Stock
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 72 institutions reported holding OKUR, with 34.9 million shares worth $159.0 million in aggregate. The largest reported holder was RA Capital Management,, with 4.0 million shares worth $18.2 million. Of the 5 largest holders listed below, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| RA Capital Management, | 3,998,333 | $18M | Unchanged |
| Bvf Inc/IL | 3,235,778 | $15M | Added 63.51% |
| Acorn Capital Advisors | 2,839,674 | $13M | Unchanged |
| Stepstone Group | 2,660,612 | $12M | Unchanged |
| Adar1 Capital Management | 2,238,684 | $10M | Reduced 8.06% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is OKUR?
OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is listed on Nasdaq, where it has traded since October 7, 2024.
Who are the largest institutional holders of OKUR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of OKUR were RA Capital Management,, Bvf Inc/IL and Acorn Capital Advisors.
How many institutions own OKUR?
72 institutions reported a position in OKUR for the quarter ended June 30, 2026, worth $159.0 million in total.
Did institutions buy or sell OKUR last quarter?
Of the 5 largest reported holders, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for OKUR.
Every reported institutional holder, plus insider and congressional trades in OKUR, on SentiSense.